Blueberry Diagnostics logo — The new gold standard for cancer detection and prevention

Blueberry Diagnostics

The new gold standard for cancer detection and prevention

Founded 2019 Spain Spain 11 employees Biotechnology, Health Care +1

General Information

Company Name Blueberry Diagnostics
Founded Year 2019
Location Spain Spain +1
Founders / Decision Makers
Team member
Employees 11
Industries Biotechnology, Health Care, Health and Wellness
Social

Get notified when Blueberry Diagnostics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Blueberry Diagnostics

Blueberry Diagnostics is a pioneering startup focused on redefining cancer detection and prevention. The company's slogan, "The new gold standard for cancer detection and prevention," encapsulates its vision to revolutionize the cancer paradigm. Blueberry Diagnostics was founded in 2019 and operates within the industries of Biotechnology, Health Care, and Health and Wellness. The company's transformative approach involves the development of innovative solutions that empower healthcare professionals globally. Blueberry Diagnostics leads the way in cancer detection with its early cancer detection and diagnosis confirmation tests, referred to as Laboratory Developed Tests (LDTs). These tests are based on routine blood and urine analyses and are powered by Deep Learning (DL) algorithms, delivering unprecedented rates of accuracy. Moreover, Blueberry Diagnostics' state-of-the-art solutions integrate scientific methodology, emphasizing outstanding cancer testing sensitivity and specificity. The company leverages its developed AI-powered algorithms to maximize the accuracy and efficiency of every test, setting a new gold standard for cancer detection. The ultimate goal is to save millions of lives through early detection. As of now, there is no specific information available regarding the company's headquarter location or its last investment and investors. In summary, Blueberry Diagnostics is positioned at the forefront of cancer detection innovation, leveraging cutting-edge technology and a commitment to saving lives through early detection.

Taxonomy: cancer detection, diagnostics solutions, LDTs, Deep Learning algorithms, clinical outcomes, non-invasive, cost-effective

No funding data available for Blueberry Diagnostics yet.

Get notified when Blueberry Diagnostics raises funding

Blueberry Diagnostics Alternatives & Competitors

Blueberry Diagnostics vs
Craif Inc.
Craif Inc. United States

Harnessing the power of urinary miRNA to detect cancer early

Non Equity Assistance
19 employees
AI, Health Care
Blueberry Diagnostics vs

Diagnostics Reimagined | Rapid Breath Tests for Disease Detection | Covid-19, Lung Cancer and more

Seed
7 employees
Biotechnology, Health Care
Blueberry Diagnostics vs
Canary Foundation
Canary Foundation United States

Early Detection Saves Lives

8 employees
Biotechnology, Education

FAQ About Blueberry Diagnostics

The new gold standard for cancer detection and prevention
Blueberry Diagnostics was founded in 2019.
Blueberry Diagnostics is headquartered in Spain.
Blueberry Diagnostics operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Blueberry Diagnostics has approximately 11 employees.
Top alternatives and competitors to Blueberry Diagnostics include Craif Inc., Breathonix Pte Ltd, Canary Foundation, JaxBio, Ophiomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Blueberry Diagnostics and Craif Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Blueberry Diagnostics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy